True Hemp’s line of hemp-seed based pet chews, dental sticks, and supplement oils will now be adorned with a National Animal Supplement Council quality program seal.
True Leaf Medicine International, a Canadian-based wellness brand for people and animals, has received National Animal Supplement Council (NASC) certification for its True Hemp line of hemp-seed based pet chews, dental sticks, and supplement oils.
The NASC quality seal program was developed to identify products from companies committed to quality, vigilance, and continuous improvement to promote the well-being of companion animals and horses.
“NASC is one of the highest-level certifications in the pet industry,” True Leaf Founder and CEO Darcy Bomford said.
RELATED:
The company received the NASC seal after successfully passing a thorough quality audit and documentation review. The quality seal program is a vital part of the NASC’s efforts to help elevate and standardize the animal health supplement industry. To display the quality seal on a product, NASC member companies must successfully pass an independent facility audit every 2 years.
In addition, the companies must demonstrate ongoing compliance with criteria, including having a quality control manual in place that provides written standard operating procedures for production process control, submit to random product testing, and comply with stringent labeling guidelines.
True Hemp products are sold in more than 1800 stores across North America and Europe.
“Our True Hemp products will now display the NASC seal,” Bomford said, “meaning True Leaf has committed to the highest current standards of quality and safety in the animal supplement industry today.”
Clemson University breaks ground on South Carolina’s first veterinary school
Published: November 23rd 2024 | Updated: November 24th 2024The Harvey S. Peeler Jr College of Veterinary Medicine is one of several institutions that plans to welcome an inaugural class of veterinary students in 2026.
Read More
Oral solution approved by the FDA for canine heart failure
November 22nd 2024Vetmedin Solution from Boehringer Ingelheim is indicated for treatment of cases caused by myxomatous mitral valve disease or dilated cardiomyopathy and is the first oral solution approved by the FDA for this use in dogs
Read More